Vaccines Improve Public Opinion Of Pharma, Despite Cost Worries With Chart: Public Holds Favorable Views of Big Pharma, But Still Wants Drug Pricing Reforms

In recent years, the pharmaceutical industry has not been popular with the public: Problems like the rising cost of prescription drugs and the opioid epidemic combined to make the industry the least popular nationwide in a 2019 Gallup poll. According to a recent poll, the public now thinks better of the industry due to the rapid development of COVID-19 vaccines — but still wants drug prices to be reined in.

In a March 2021 national survey, progressive polling group Data for Progress found that 56% of respondents had a favorable view of pharmaceutical companies (see infographic, p. 6). Vaccine developers scored well on an individual basis: majorities had favorable views of Johnson & Johnson (68%), Moderna, Inc. (60%) and Pfizer Inc. (65%). Also, 75% of respondents said they approve of those specific companies’ vaccine development efforts. However, the poll also found that 73% of respondents disapprove of “how pharmaceutical companies are handling the rising cost of prescription drugs.”

© 2022 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

workers-prepping-infusion-drug
May 12

Major PBMs Look Ahead to 2023 for Biosimilars Boom

READ MORE
wall-street-sign
May 12

Centene Plans to Sell Magellan Rx, PANTHERx Rare for $2.8 Billion

READ MORE
pills-and-dollars
May 12

Study: With High Prices, Rebate Revenue Is Growing for PBMs

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today